Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell in late action.

Robert F. Kennedy Jr. and I rarely see eye to eye, but I’ll grudgingly admit he’s not entirely wrong about food dyes, though ...

In its first-quarter results update, MSD – which is known as Merck & Co in the US and Canada – said it expects full-year ...

Find insight on Merck, Sanofi and more in the latest Market Talks covering the Health Care sector.